Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT ID: NCT00622037
Last Updated: 2010-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
70 participants
INTERVENTIONAL
2008-02-29
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
NCT00620893
Artificial Tears Study in Mild to Moderate Dry Eye Patients
NCT00607776
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678
Clinical Study Aimed At Evaluating the Safety and Efficacy of Tear Substitute Formulations in the Treatment of Dry Eye Disease.
NCT06633471
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02831387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
PEG-400 based artificial tear
PEG-400 based artificial tear
Instill one drop in the randomized eye four times daily. Can be used more frequently if needed
2
Systane
Systane
Instill one drop in the randomized eye four times daily. Can be used more frequently if needed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PEG-400 based artificial tear
Instill one drop in the randomized eye four times daily. Can be used more frequently if needed
Systane
Instill one drop in the randomized eye four times daily. Can be used more frequently if needed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physician assessment of mild-moderate dry eye
* Patient willing to instill drops QID and complete entire length of protocol.
* TBUT \< 10 seconds
* BCVA of 20/30 or better
Exclusion Criteria
* Current Systane use
* Refractive surgery within the last 6 months
* Oral or topical corticosteroid use
* Severe dry eye patients by physician assessment
* current active Blepharitis
* Oral Doxycyclines use
* Oral Antihistamine use
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bp Consulting, Inc
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Florida Microsurgical Eye Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barry Schechter, MD
Role: PRINCIPAL_INVESTIGATOR
Florida Microsurgical Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Florida Microsurgical Eye Institute
Boynton Beach, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5338
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.